Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
1997
Infective Endocarditis
2005 Standout
Vancomycin Use in a University Medical Center: Comparison With Hospital Infection Control Practices Advisory Committee Guidelines
1996
Disinfection of Hospital Rooms Contaminated With Vancomycin-Resistant Entemcocms faecium
1998
The Structural Basis for mRNA Recognition and Cleavage by the Ribosome-Dependent Endonuclease RelE
2009 StandoutNobel
Clinical impact of antibiotic-resistant Gram-positive pathogens
2009
Management of catheter-related bacteremia and fungemia in patients on total parenteral nutrition
1997
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
1999
The Incidence of and Clinical Variables Associated With Vancomycin-Resistant Enterococcal Colonization in Mechanically Ventilated Patients
1999
Vancomycin‐Resistant and Vancomycin‐Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes
1998
Is There a Relationship Between Vancomycin‐Resistant Enterococcal Infection and Clostridium difficile Infection?
1997
A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment
2006 Standout
Manipulation of a Hospital Antimicrobial Formulary to Control an Outbreak of Vancomycin-Resistant Enterococci
1996
Marine natural products
1990 Standout
Enterococcus faecalis: Its Role in Root Canal Treatment Failure and Current Concepts in Retreatment
2006 Standout
Vancomycin-Resistant Enterococci Outside the Health-Care Setting: Prevalence, Sources, and Public Health Implications
1997
Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium
2003
Infection Control — A Problem for Patient Safety
2003 Standout
Axe–Txe, a broad‐spectrum proteic toxin–antitoxin system specified by a multidrug‐resistant, clinical isolate of Enterococcus faecium
2003
A Prospective Study to Determine Whether Cover Gowns in Addition to Gloves Decrease Nosocomial Transmission of Vancomycin-Resistant Enterococci in an Intensive Care Unit
2002
Infection Control in the ICU
2001
Changing Epidemiology of Infections in Patients with Neutropenia and Cancer: Emphasis on Gram-Positive and Resistant Bacteria
1999
Multiple Antibiotic–Resistant Bacteria in Long‐Term‐Care Facilities: An Emerging Problem in the Practice of Infectious Diseases
2000
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
2005 Standout
Guideline for Prevention of Intravascular-Device–Related Infections
1996
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Guideline for Prevention of Intravascular-Device-Related Infections
1996
Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses
2005
Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin‐Resistant Enterococcus in a Level 1 Trauma Center
2002
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Prolonged Colonization with Vancomycin‐ResistantEnterococcus faeciumin Long‐Term Care Patients and the Significance of “Clearance”
2001
Natural History of Colonization with Vancomycin-Resistant Enterococcus Faecium
1995
Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection
2012
Vancomycin-resistant enterococcal infections in bone marrow transplant recipients
1998
Genomic and Functional Characterization of Enterococcus faecalis Isolates Recovered From the International Space Station and Their Potential for Pathogenicity
2021 StandoutNobel
Selective pressure by antibiotic use in livestock
2000
Antimicrobial management measures to limit resistance: A process-based conceptual framework
2001
Antimicrobial Resistance Prevalence Rates in Hospital Antibiograms Reflect Prevalence Rates among Pathogens Associated with Hospital‐Acquired Infections
2001
Reasons for Noncompliance With Infection Control Guidelines
2000
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study
2006 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: Association with antibiotic usage
1998
The Role of Chloramphenicol in the Treatment of Bloodstream Infection Due to Vancomycin‐ResistantEnterococcus
1998
Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia
2002
Enterococcal Bacteremia: Risk Factors for Vancomycin Resistance and Predictors of Mortality
1999
Risk Factors Associated with Vancomycin-Resistant Enterococcus faecium Infection or Colonization in 145 Matched Case Patients and Control Patients
1996
Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients
2000
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Changes in the Etiology of Bacteremia in Febrile Neutropenic Patients and the Susceptibilities of the Currently Isolated Pathogens
2004
Resistance to Glycopeptides in Enterococci
1997
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia☆
2000
Persistence of Vancomycin-Resistant Enterococcus faecium Gastrointestinal Tract Colonization in Antibiotic-Treated Mice
1996
Revised Estimates for the Number of Human and Bacteria Cells in the Body
2016 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection
1996
The epidemiology of vancomycin-resistant enterococci
1999
Vancomycin‐Resistant Enterococcus faecium in a Long‐Term Care Facility
1998
The Role of "Colonization Pressure" in the Spread of Vancomycin-Resistant Enterococci
1998
Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
2007
Vancomycin-resistant enterococci: 15 years and counting
2003
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Attributable Mortality of Nosocomial Candidemia, Revisited
2003
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Infective endocarditis
2004 Standout
Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
2003
Guideline for Prevention of Intravascular-Device–Related Infections
1996
Nosocomial Infections with Vancomycin-Resistant Enterococcus fuecium in Liver Transplant Recipients: Risk Factors for Acquisition and Mortality
1996
Health and Economic Outcomes of Vancomycin-Resistant Enterococci
2002
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
Antibiotic-Associated Diarrhea
2002 Standout
Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome
2002
Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/Dalfopristin
2001
Impact of Vancomycin Resistance on Mortality among Patients with Neutropenia and Enterococcal Bloodstream Infection
2005
The Attributable Mortality and Costs of Primary Nosocomial Bloodstream Infections in the Intensive Care Unit
1999
Ventilator-associated Pneumonia
2002 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Fulminant Late-Onset Sepsis in a Neonatal Intensive Care Unit, 1988–1997, and the Impact of Avoiding Empiric Vancomycin Therapy
2000
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Gut Microbiota in Health and Disease
2010 Standout
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model
1996
Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections
2002 Standout
Spread of Vancomycin-Resistant Enterococci: Why Did It Happen in the United States?
1998
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Vancomycin-resistant enterococci: why are they here, and where do they come from?
2001
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Preventing Complications of Central Venous Catheterization
2003 Standout
Practice Guidelines for the Management of Infectious Diarrhea
2001
Reference Group Choice and Antibiotic Resistance Outcomes
2004
Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study
2001
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital
1997
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Invasive Candidiasis
2015 Standout
Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile -Associated Disease
2008
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network
2002 Standout
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
Antibiotic Resistance in the Intensive Care Unit
2001
HOW NEUTROPHILS KILL MICROBES
2005 Standout
In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria
2000
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
Loloatin B, A cyclic decapeptide antibiotic produced in culture by a tropical marine bacterium
1996
Pathogenicity of Enterococci
2019
Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysis
2005
Antibiotic Resistance Genes as Emerging Contaminants: Studies in Northern Colorado
2006 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of J. Ober being referenced
Vancomycin-Resistant Enterococcus faecium Bacteremia: Risk Factors for Infection
1995
Vancomycin-Resistant Enterococcal Bacteremia: Natural History and Attributable Mortality
1996
Antibiotic-Resistant Bloodstream Infections in Hospitalized Patients: Specific Risk Factors in a High–Risk Population?
2005